Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 24, 2016 - Issue 2
Submit an article Journal homepage
618
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

A Case Series and Review of Bisphosphonate-associated Orbital Inflammation

Daniel R. LefebvreOphthalmic Plastic Surgery Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA, ;Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA, Correspondence[email protected]
, MD,
John T. MandevilleDepartment of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA, ;Eye Health Services, Inc., Quincy, Massachusetts, USA,
, MD, PhD,
Yoshihiro YonekawaDepartment of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA,
, MD,
Jorge G. ArroyoDepartment of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA, ;Beth Israel Deaconess Medical Center, Division of Ophthalmology, Boston, Massachusetts, USA
, MD, MPH,
Nurhan TorunDepartment of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA, ;Beth Israel Deaconess Medical Center, Division of Ophthalmology, Boston, Massachusetts, USA
, MD &
Suzanne K. FreitagOphthalmic Plastic Surgery Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA, ;Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA,
, MD
Pages 134-139 | Received 14 Mar 2014, Accepted 04 Jul 2014, Published online: 25 Aug 2014

References

  • Kunzmann V, Bauer E, Feurle J, et al. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood. 2000;96:384–392
  • Fraunfelder FW, Fraunfelder FT, Jensvold B. Scleritis and other ocular side effects associated with pamidronate disodium. Am J Ophthalmol. 2003;135:219–222
  • Patel DV, Horne A, House M, et al. The incidence of acute anterior uveitis after intravenous zoledronate. Ophthalmology. 2013;120:773–6
  • Papapetrou PD. Bisphosphonate-associated adverse events. Hormones. 2009;8:96–110
  • Benderson D, Karakunnel J, Kathuria S, Badros A. Scleritis complicating zoledronic acid infusion. Clin Lymphoma Myeloma. 2006;7:145–147
  • Peterson JD, Bedrossian EH Jr. Bisphosphonateassociated orbital inflammation: a case report and review. Orbit. 2012;31:119–123
  • Ginat DT, Freitag SK, Kieff D, et al. Radiographic patterns of orbital involvement in IgG4-related disease. Ophthal Plast Reconstr Surg. 2013;29:261--266
  • Ginat DT, Freitag SK, et al. Radiographic patterns of orbital involvement in IgG4-related disease. Ophthalmol Plast Reconstr Surg. 2013; [Epub ahead of print]
  • Mbekeani JN, Slamovits TL, Schwartz BH, Sauer HL. Ocular inflammation associated with alendronate therapy. Arch Ophthalmol. 1999;117:837–838
  • Ryan PJ, Sampath R. Idiopathic orbital inflammation following intravenous pamidronate. Rheumatology (Oxford). 2001;40:956–957
  • Subramanian PS, Kerrison JB, Calvert PC, et al. Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer. Arch Ophthalmol. 2003;121:1335–1336
  • Phillips PM, Newman SA. Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma. Arch Ophthalmol. 2008;126:137–139
  • Sharma NS, Ooi JL, Masselos K, et al. Zoledronic acid infusion and orbital inflammatory disease. N Engl J Med. 2008;359:1410–1411
  • Procianoy F, Procianoy E. Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis. Osteoporos Int. 2010;21:1057–1058
  • Seth A, Anderson DP, Albiani DA, et al. Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer. Can J Ophthalmol. 2009;44:467–468
  • Yang EB, Birkholz ES, Lee AG. Another case of bisphosphonate induced orbital inflammation. J Neuroophthalmol. 2010;30:94–95
  • Missotten G, Verheezen Y. Orbital inflammation after use of zoledronic acid for metastasized prostate carcinoma. Bull Soc Belge Ophthalmol. 2010;315:23–24
  • Yeo J, Jafer AK. Zolendronate associated inflammatory orbital disease. N Z Med J. 2010;123:50–52
  • Boni C, Kordic H, Chaloupka K. Bisphosphonate-associated orbital inflammatory disease and uveitis anterior—a case report and review. Klin Monbl Augenheilkd. 2013;230:367–369
  • Reid IR, Gamble GD, et al. Characterization of and risks for the acute-phase response after zoledronic acid. J CLin Endocrinol Metab. 2010;95:4380–4387
  • Dicuonzo G, Vincenzi B, Santini D, et al. Fever after zoledronic acid administration is due to increase in TNF-and IL-6. J Interferon Cytokine Res. 2003;23:649–654
  • French DD, Margo CE. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. Retina. 2008;28:889–893
  • Mondelo N, Peluffo V, Parma M, et al. Toxicologia preclinical de bisfosfonatos. Medicina (B Aires). 1997;57:93–100

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.